Brief: Scancell And Neuphoria Therapeutics Announce Merger Agreement And Financing
23/07/2026 11:13
BRIEF-Scancell And Neuphoria Therapeutics Announce Merger Agreement And Financing July 23 (Reuters) - Neuphoria Therapeutics Inc NEUP.O:
SCANCELL AND NEUPHORIA THERAPEUTICS ANNOUNCE MERGER AGREEMENT AND FINANCING
SCANCELL AND NEUPHORIA THERAPEUTICS ANNOUNCE MERGER AGREEMENT AND FINANCING
NEUPHORIA THERAPEUTICS - SCANCELL TO BUY NEUPHORIA IN ALL-SHARE MERGER
NEUPHORIA THERAPEUTICS - SCANCELL EXPECTS TO SECURE UP TO $89 MILLION IN FINANCING
NEUPHORIA THERAPEUTICS - SCANCELL SHAREHOLDERS TO OWN 85.5%, NEUPHORIA SHAREHOLDERS 14.5% OF COMBINED COMPANY
Source text: ID:nGNX50mbrP
Further company coverage: NEUP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neuphoria Therapeutics
See all newsBrief: Scancell And Neuphoria Therapeutics Announce Merger Agreement And Financing
NASDAQ RESUMED AT 03:25 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 03:20 PM
Brief: Neuphoria Therapeutics Confirms Discussions On Potential Acquisition By Scancell
Brief: Neuphoria Responds To Lynx1’S Revised Indication Of Interest At A Reduced Price And Premium